Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
National Institutes of Health
Funding Amount
Varies
Deadline
January 7, 2028
639 days left
Grant Type
federal
Overview
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders. Applications are sought that will either 1) develop novel brain stimulation devices or 2) significantly enhance, by means of hardware/software improvements, the effectiveness of brain stimulation devices that are currently U.S. Food and Drug Administration (FDA)-approved or cleared. Novel devices should move beyond existing electrical/magnetic stimulation and develop new stimulation techniques capable of increased spatiotemporal precision as well as multi-focal, closed-loop approaches. Applications seeking to develop new capabilities should focus on significant enhancement of the spatial resolution, depth of delivery, and/or precision of the device. Incremental changes to existing devices (e.g., software updates)are not within the scope of this announcement. Applications should be submitted by multi-disciplinary teams with a variety of expertise including systems neuroscience, engineering, clinical, and regulatory affairs.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: PAR-25-286
- Instrument: grant
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Eligibility
Eligible Applicant Types
How to Apply
PAR-25-286 Full Announcement Text
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta http-equiv="refresh" content="0; URL='http://grants.nih.gov/grants/guide/pa-files/PAR-25-286.html'" />
<title>PAR-25-286</title>
</head>
<body>
</body>
</html>
Focus Areas & Funding Uses
Fields of Work
Categories
Browse similar grants by category
Related Grants
Similar grants from this funder and related organizations
Implementing Zero Suicide in Health Systems
Substance Abuse and Mental Health Services Adminis
Amount
$0 - $700,000
Deadline
April 20, 2026
BJA FY25 Residential Substance Abuse Treatment for State Prisoners – Formula Grants Program
Bureau of Justice Assistance
Amount
$0 - $1,207,840
Deadline
April 20, 2026
Children's Mental Health Initiative
Substance Abuse and Mental Health Services Adminis
Amount
$0 - $3,000,000
Deadline
April 20, 2026
BJA FY25 Public Safety and Mental Health Initiative Training and Technical Assistance
Bureau of Justice Assistance
Amount
$0 - $3,200,000
Deadline
April 20, 2026
Assisted Outpatient Treatment Program
Substance Abuse and Mental Health Services Adminis
Amount
$0 - $750,000
Deadline
April 20, 2026
Innovation in Behavioral Health (IBH)
Center for Medicare and Medicaid Services
Amount
$0 - $7,500,000
Deadline
June 3, 2026
Ready to apply for Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.